Peter Attia· MD
and Alzheimer's disease actually I think is more closely related to cardiovascular disease in terms of risk stratification so first of all knowing the patient's apoE immediately gives me a bucket to put them in which is you know low medium high risk I mean that's I don't call it that but that's sort of how you can think about it and then you look at the other dimensions of it which is there's a vascular component to that disease and that basically proxy what you're seeing in cardiovascular risk so the more you can improve the cardio metabolic profile the more you can improve that then there's the metabolic component period which is kind of like the glucose utilization part